Zoledronic acid monohydrate contains not less than 98.0% and not more than 101.0% of C5H10N2O7P2‧H2O, calculated on the dried basis.

共有 1 個藥物證書使用此成份

諾雷卓尼克酸
Zoledronic acid monohydrate

• 申請商: 川聖貿易股份有限公司
• 適應症: 惡性腫瘤之高血鈣症
• 發證日期: 2013-02-05